These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 14506657)

  • 21. Prevention of cytomegalovirus disease in hematopoietic stem cell transplantation.
    Zaia JA
    Clin Infect Dis; 2002 Oct; 35(8):999-1004. PubMed ID: 12355388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus Infections after Hematopoietic Stem Cell Transplantation: Current Status and Future Immunotherapy.
    Cho SY; Lee DG; Kim HJ
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomegalovirus infection: the point in 2001.
    Salmon-Ceron D
    HIV Med; 2001 Oct; 2(4):255-9. PubMed ID: 11737406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of CMV disease in HIV infection.
    Williams IG
    Int J STD AIDS; 1999 Apr; 10(4):211-6; quiz 216-9. PubMed ID: 12035772
    [No Abstract]   [Full Text] [Related]  

  • 25. Strategies for management of cytomegalovirus (CMV) infection after allogeneic bone marrow transplantation: the "doubling of baseline CMV pp65 antigenemia" and the "cidofovir as rescue treatment approaches.
    Castagnola E; Miano M; Morreale G; Cristina E; Chierici M; Lanino E
    Blood; 2001 Sep; 98(5):1627-8; author reply 1628-9. PubMed ID: 11547769
    [No Abstract]   [Full Text] [Related]  

  • 26. Acyclovir versus valganciclovir for preventing cytomegalovirus infection in intermediate-risk liver transplant recipients.
    McKeen JT; Tsapepas DS; Li H; Anamisis A; Martin ST
    Prog Transplant; 2015 Mar; 25(1):39-44. PubMed ID: 25758799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic and immunologic management of cytomegalovirus infection after solid organ and hematopoietic stem cell transplantation.
    Meesing A; Razonable RR
    Expert Rev Clin Pharmacol; 2018 Aug; 11(8):773-788. PubMed ID: 30009675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences of cytomegalovirus diseases between kidney and hematopoietic stem cell transplant recipients during preemptive therapy.
    Kim T; Lee YM; Lee SO; Choi SH; Kim YS; Woo JH; Sung H; Jung JH; Shin S; Kim YH; Kang YA; Lee YS; Lee JH; Lee JH; Lee KH; Park SK; Han DJ; Kim SH
    Korean J Intern Med; 2016 Sep; 31(5):961-70. PubMed ID: 27055664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gastrointestinal cytomegalovirus infections in organ transplant patients].
    Péter A; Telkes G; Varga M; Járay J
    Orv Hetil; 2008 Dec; 149(52):2463-70. PubMed ID: 19087914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral therapy for cytomegalovirus infections in pediatric patients.
    Kimberlin DW
    Semin Pediatr Infect Dis; 2002 Jan; 13(1):22-30. PubMed ID: 12118840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of cytomegalovirus diseases.
    Vogel JU; Scholz M; Cinatl J
    Intervirology; 1997; 40(5-6):357-67. PubMed ID: 9675640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
    Ljungman P; Deliliers GL; Platzbecker U; Matthes-Martin S; Bacigalupo A; Einsele H; Ullmann J; Musso M; Trenschel R; Ribaud P; Bornhäuser M; Cesaro S; Crooks B; Dekker A; Gratecos N; Klingebiel T; Tagliaferri E; Ullmann AJ; Wacker P; Cordonnier C
    Blood; 2001 Jan; 97(2):388-92. PubMed ID: 11154213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients.
    Nguyen Q; Champlin R; Giralt S; Rolston K; Raad I; Jacobson K; Ippoliti C; Hecht D; Tarrand J; Luna M; Whimbey E
    Clin Infect Dis; 1999 Mar; 28(3):618-23. PubMed ID: 10194088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
    Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
    Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution.
    Melendez-Munoz R; Marchalik R; Jerussi T; Dimitrova D; Nussenblatt V; Beri A; Rai K; Wilder JS; Barrett AJ; Battiwalla M; Childs RW; Fitzhugh CD; Fowler DH; Fry TJ; Gress RE; Hsieh MM; Ito S; Kang EM; Pavletic SZ; Shah NN; Tisdale JF; Gea-Banacloche J; Kanakry CG; Kanakry JA
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):577-586. PubMed ID: 30342913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation.
    Cesaro S; Zhou X; Manzardo C; Buonfrate D; Cusinato R; Tridello G; Mengoli C; Palù G; Messina C
    J Clin Virol; 2005 Oct; 34(2):129-32. PubMed ID: 16157264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients.
    Ljungman P; Aschan J; Lewensohn-Fuchs I; Carlens S; Larsson K; Lönnqvist B; Mattsson J; Sparrelid E; Winiarski J; Ringdén O
    Transplantation; 1998 Nov; 66(10):1330-4. PubMed ID: 9846518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic developments in cytomegalovirus retinitis.
    Hoffman VF; Skiest DJ
    Expert Opin Investig Drugs; 2000 Feb; 9(2):207-20. PubMed ID: 11060672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial.
    Witzke O; Hauser IA; Bartels M; Wolf G; Wolters H; Nitschke M;
    Transplantation; 2012 Jan; 93(1):61-8. PubMed ID: 22094954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.